Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] traded at a low on Monday, posting a -6.56 loss after which it closed the day’ session at $2.85.
The results of the trading session contributed to over 26238824 shares changing hands. Over the past one week, the price volatility of Biodexa Pharmaceuticals Plc ADR stands at 20.04% while the volatility over the past one month is 18.53%.
The market cap for BDRX stock reached $1.65 million, with 0.36 million shares outstanding. Compared to the average trading volume of 441.14K shares, BDRX reached a trading volume of 26238824 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Biodexa Pharmaceuticals Plc ADR [BDRX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BDRX shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BDRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Biodexa Pharmaceuticals Plc ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 08, 2024.
The Average True Range (ATR) for Biodexa Pharmaceuticals Plc ADR is set at 0.56, with the Price to Sales ratio for BDRX stock in the period of the last 12 months amounting to 16.53. The Price to Book ratio for the last quarter was 0.22, with the Price to Cash per share for the same quarter was set at 11.02.
How has BDRX stock performed recently?
Biodexa Pharmaceuticals Plc ADR [BDRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.39. With this latest performance, BDRX shares dropped by -31.65% in over the last four-week period, additionally sinking by -71.21% over the last 6 months – not to mention a drop of -91.16% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BDRX stock in for the last two-week period is set at 32.18, with the RSI for the last a single of trading hit 28.33, and the three-weeks RSI is set at 35.46 for Biodexa Pharmaceuticals Plc ADR [BDRX]. The present Moving Average for the last 50 days of trading for this stock 4.08, while it was recorded at 2.96 for the last single week of trading, and 11.00 for the last 200 days.
Biodexa Pharmaceuticals Plc ADR [BDRX]: Deeper insight into the fundamentals
Biodexa Pharmaceuticals Plc ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.16 and a Current Ratio set at 2.16.
Earnings analysis for Biodexa Pharmaceuticals Plc ADR [BDRX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BDRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Biodexa Pharmaceuticals Plc ADR go to 89.98%.
